
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of SIRT5 in cancer. Friend or Foe?
Francisco Alejandro Lagunas‐Rangel
Biochimie (2023) Vol. 209, pp. 131-141
Closed Access | Times Cited: 9
Francisco Alejandro Lagunas‐Rangel
Biochimie (2023) Vol. 209, pp. 131-141
Closed Access | Times Cited: 9
Showing 9 citing articles:
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Sirtuins in intervertebral disc degeneration: current understanding
Jianlin Shen, Yujian Lan, Ziyu Ji, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 7
Jianlin Shen, Yujian Lan, Ziyu Ji, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 7
Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications
Francisco Alejandro Lagunas‐Rangel
Frontiers in Oncology (2025) Vol. 15
Open Access
Francisco Alejandro Lagunas‐Rangel
Frontiers in Oncology (2025) Vol. 15
Open Access
The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy
Yujing Tang, Wantao Ju, Y. Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Yujing Tang, Wantao Ju, Y. Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
The dark side of SIRT7
Francisco Alejandro Lagunas‐Rangel
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2843-2861
Closed Access | Times Cited: 8
Francisco Alejandro Lagunas‐Rangel
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2843-2861
Closed Access | Times Cited: 8
Transcriptional activation of SIRT5 by FOXA1 reprograms glycolysis to facilitate the malignant progression of diffuse large B-cell lymphoma
Ye Zhang, Peng Lu, Shenhe Jin, et al.
Cellular Signalling (2024) Vol. 123, pp. 111356-111356
Closed Access | Times Cited: 2
Ye Zhang, Peng Lu, Shenhe Jin, et al.
Cellular Signalling (2024) Vol. 123, pp. 111356-111356
Closed Access | Times Cited: 2
Post-translational modulation of cell signalling through protein succinylation
Katharina F. Kubatzky, Yue Gao, Dayoung Yu
Exploration of Targeted Anti-tumor Therapy (2023) Vol. 4, Iss. 6, pp. 1260-1285
Open Access | Times Cited: 4
Katharina F. Kubatzky, Yue Gao, Dayoung Yu
Exploration of Targeted Anti-tumor Therapy (2023) Vol. 4, Iss. 6, pp. 1260-1285
Open Access | Times Cited: 4
Self-assembled peptide-based nanoforms targeting mitochondria for chemotherapy
Isha Isha, Pooja Rani, Monica Gulati, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 106006-106006
Closed Access
Isha Isha, Pooja Rani, Monica Gulati, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 106006-106006
Closed Access
Emerging role of sirtuins in non‑small cell lung cancer (Review)
Min Zhou, Wei Lin, Renfu Lu
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access
Min Zhou, Wei Lin, Renfu Lu
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access